Position
BRAIDWELL LP in X4 Pharmaceuticals, Inc
Back to the book · All holders of XFOR
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $425.5K$4.00 → $4.13
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 3.37M | $13.5M | — | — | — | 0.4% |
| Q1 2026 | 3.27M | $13.5M | $4.13 | $425.5K | −$383.8K | 0.5% |